Posts

Sensex Gains Over 130 Points in Noon Deals: Nifty50 Remains Flat; Bajaj Electricals, Redington, and Tata Motors Among Buzzing Stocks

  The Indian stock market is showing a cautious but steady mood this Tuesday afternoon, March 17, 2026. As traders settle into the post-lunch session, the BSE Sensex has climbed more than 130 points, while the NSE Nifty50 is hovering almost flat. It’s one of those typical mid-session days where optimism flickers but global jitters keep the bulls on a short leash. If you’re someone who tracks every tick on your trading app, this update is for you. Let’s break down what’s really happening, why certain stocks are suddenly in the spotlight, and what it might mean for your portfolio. Market Snapshot at Noon: Sensex Up, Nifty50 Steady At around 12:30 PM IST, the Sensex was trading higher by roughly 130–150 points (around 0.17–0.20%), comfortably above the 75,900 level after opening with mild gains. The Nifty50 , on the other hand, refused to budge much — staying almost flat near 23,400–23,500 after swinging between small gains and losses. This mixed picture comes after Monday’s dec...

Top 10 Stocks to Buy on Dip in 2026: LINDEINDIA Leads the Charge Amid Market Volatility

Engineers India Shares Zoom 16% as Q3 Profit Surges 219% YoY to ₹347 Crore – Key Earnings Highlights & What It Means

Bloodbath in IT Stocks: NIFTY IT Tanks Over 10% in 2 Sessions – Why is the Rout Intensifying?

Eyewear Giant Lenskart Reports Explosive Q3 – Profit Multiplies 70x to ₹131 Cr, Revenue Rises 38%

United Breweries Q3 Results 2026: Net Profit Surges 111% to ₹81 Crore Despite 11% Revenue Dip – Shares Rise on Margin Strength

MCX Silver Surges 4% to ₹2.62 Lakh/kg on February 11, 2026 – Gold Climbs 1% as US Dollar Weakens

Nifty Ends at 25,953, Sensex Down 40 pts: Auto Rally Powers Mixed Market Close – Feb 11 Recap

Why Kalyan Jewellers Stock Jumped Nearly 12% Today: Q3 Profit Soars 90%, Revenue Hits Rs 10,343 Crore – Analyst Targets Inside

SEBI Approves ₹10,000 Crore IPO Wave: InCred, Laser Power, SEDEMAC Among 8 Cleared

Top Pharma and Biopharma Companies Poised to Benefit